Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Small-Cap Stocks With Monster Upsides, According to Wall Street

TheMotleyFool

0 0

2 Small-Cap Stocks With Monster Upsides, According to Wall Street: https://g.foolcdn.com/editorial/images/676731/gettyimages-1329363820.jpg

Shares of small-cap stocks are typically more likely to double (or more) in a short period, say, one year. But these companies also tend to be substantially riskier than more-established corporations. That's why it's essential to proceed with extreme caution when looking at these smaller companies.

With that in mind, let's look at two small-cap stocks that boast significant upside potential, at least if we go by average price targets assigned by Wall Street analysts. The companies in question are Ocugen (NASDAQ: OCGN) and BioXcel Therapeutics (NASDAQ: BTAI). Are these biotech stocks worth buying right now?